# Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma

> **NCT01265147** · PHASE2 · UNKNOWN · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Nedaplatin

## Key facts

- **NCT ID:** NCT01265147
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-12
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01265147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01265147, "Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01265147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*